Scientists and physicians can better assess precision genome editing technology using a new method made public today by St. Jude Children’s Research Hospital. Significant amounts of time and resources spent improving CRISPR gene editing technology focus on identifying small off-target sites that pose a safety risk, which is also technically challenging.